Rebalix
Logo iSharesiShares · sheet of 5 September 2026
ETF sheet · official issuer and register data

iShares World Equity Factor Rotation Active UCITS ETF

FACT · IE0009Y1MQJ2 · USD · domicile Ireland
Equity · Global · All sizesactiveSFDR art. 8
Comparison benchmark: MSCI World Index (Net)
TER
0.30%+ trans. 0.05%
Fund size
222 m EUR
Tracking difference
+0.00%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Gestione attiva (dal KID)active management
Income
Accumulating
Launch 16 Jan 2025 · costs from the KID as of 2 Sept 2026 · 402 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is actively managed and aims to achieve long-term capital growth by primarily investing in a portfolio of equity securities with diversified and tactical exposure to style factors via a factor rotation model. The Fund seeks to gain at least 80% of its investment exposure to equity securities (e.g. shares) of companies domiciled in, listed in, or the main business of which is in, global developed markets selected based on a proprietary factor rotation model developed by the Investment Manager and its affiliates. The Fund will also invest in…

Performance since series start (in euro) — base 100

16 Jan 202531 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202612182119
High 121 (13 Aug 2026) · low 82 (8 Apr 2025) · last 119. Past performance is not indicative of future results.

Returns in euro

1 year+18.9%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+19.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.07%13.07%
Max drawdown−9.43%−9.43%
Sharpe1.271.27
Sortino1.901.90
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · FACT · IE0009Y1MQJ21
RebalixFACT · IE0009Y1MQJ2 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+0.00%+0.00%+0.00%
2024+0.00%+0.00%+0.00%
2023+0.00%+0.00%+0.00%
2022+0.00%+0.00%+0.00%
2021+0.00%+0.00%+0.00%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 402 securities · top-10 weight = 29.2%
Top holdingsWeight
NVIDIA6.0%
APPLE5.4%
MICROSOFT3.5%
AMAZON.COM INC3.1%
JPMORGAN CHASE & CO2.6%
EXXONMOBIL HOLDINGS CORP2.0%
BROADCOM INC1.9%
ALPHABET CLASS A1.8%
BANK OF AMERICA1.6%
META PLATFORMS CLASS A1.6%
Countries (% of fund)
United States72.5%Japan7.2%United Kingdom3.5%France2.1%Switzerland1.9%
Sectors (% of fund)
Information Technology31.8%Financials19.3%Industrials11.5%Communication8.9%Health Care7.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
FCRN · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/fact-ishares-world-
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE0009Y1MQJ2
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · FACT · IE0009Y1MQJ22